CellaVision AB Total Liabilities

Latest as of December 2025: Skr207.31 Million SEK ≈ $22.31 Million USD

CellaVision AB total liabilities. Based on the latest financial reports, CellaVision AB (CEVI) has total liabilities worth Skr207.31 Million SEK (≈ $22.31 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check CEVI asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of CellaVision AB (2000–2025)

Total liabilities of CellaVision AB from 2000 to 2025. This chart illustrates how CellaVision AB's total liabilities have evolved over time, based on quarterly financial data. Explore CEVI long-term asset investment ratio to see how much of total assets are deployed in long-term investments.

CellaVision AB Competitors by Total Liabilities

The table below lists competitors of CellaVision AB ranked by their total liabilities.

Company	Country	Total Liabilities
Crescent Biopharma, Inc. NASDAQ:CBIO	USA	$19.50 Million
Ambassador Hotel Ltd TW:2704	Taiwan	NT$8.09 Billion
EV MOTORS, S.A. MC:EBROM	Spain	€419.19 Million
OPTHEA LTD (SP.ADR/8) F:UKJ2	Germany	€314.48 Million
Okea ASA OL:OKEA	Norway	Nkr1.96 Billion
Kofola CeskoSlovensko as PR:KOFOL	Czech Republic	Kč9.06 Billion
Zhe Jiang Li Zi Yuan Food Co Ltd SHG:605337	China	CN¥1.59 Billion
Kearny Financial Corp NASDAQ:KRNY	USA	$6.86 Billion

Liability Composition Analysis (2000–2025)

This chart breaks down CellaVision AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see CellaVision AB asset portfolio.

Liquidity & Leverage Metrics

CellaVision AB Total Liabilities Ratios Explained

CellaVision AB total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	3.98	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.23	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.19	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how CellaVision AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for CellaVision AB (2000–2025)

The table below shows the annual total liabilities of CellaVision AB from 2000 to 2025.

Year	Total Liabilities	Change
2025-12-31	Skr207.31 Million ≈ $22.31 Million	+5.68%
2024-12-31	Skr196.16 Million ≈ $21.11 Million	-7.61%
2023-12-31	Skr212.32 Million ≈ $22.85 Million	-15.11%
2022-12-31	Skr250.12 Million ≈ $26.92 Million	-11.28%
2021-12-31	Skr281.93 Million ≈ $30.34 Million	+18.26%
2020-12-31	Skr238.41 Million ≈ $25.66 Million	-18.73%
2019-12-31	Skr293.34 Million ≈ $31.57 Million	+255.96%
2018-12-31	Skr82.41 Million ≈ $8.87 Million	+37.93%
2017-12-31	Skr59.75 Million ≈ $6.43 Million	+18.85%
2016-12-31	Skr50.27 Million ≈ $5.41 Million	+36.20%
2015-12-31	Skr36.91 Million ≈ $3.97 Million	-27.56%
2014-12-31	Skr50.95 Million ≈ $5.48 Million	-9.11%
2013-12-31	Skr56.06 Million ≈ $6.03 Million	+4.50%
2012-12-31	Skr53.64 Million ≈ $5.77 Million	+1.87%
2011-12-31	Skr52.66 Million ≈ $5.67 Million	+7.30%
2010-12-31	Skr49.08 Million ≈ $5.28 Million	+27.30%
2009-12-31	Skr38.55 Million ≈ $4.15 Million	-23.64%
2008-12-31	Skr50.49 Million ≈ $5.43 Million	+109.95%
2007-12-31	Skr24.05 Million ≈ $2.59 Million	+1.92%
2006-12-31	Skr23.60 Million ≈ $2.54 Million	+19.90%
2005-12-31	Skr19.68 Million ≈ $2.12 Million	-27.03%
2004-12-31	Skr26.97 Million ≈ $2.90 Million	+20.07%
2003-12-31	Skr22.46 Million ≈ $2.42 Million	-10.24%
2002-12-31	Skr25.02 Million ≈ $2.69 Million	-23.58%
2001-12-31	Skr32.74 Million ≈ $3.52 Million	+79.77%
2000-12-31	Skr18.21 Million ≈ $1.96 Million	--

About CellaVision AB

ST:CEVI Sweden Medical Devices

Market Cap

$512.85 Million

Skr4.77 Billion SEK

Market Cap Rank

#11797 Global

#191 in Sweden

Share Price

Skr199.80

Change (1 day)

+4.61%

52-Week Range

Skr118.40 - Skr199.80

All Time High

Skr478.48